Steven A. Everett
Oprichter bij MaveriX Oncology, Inc.
Actieve functies van Steven A. Everett
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | 09-06-2011 | - |
MaveriX Oncology, Inc.
 MaveriX Oncology, Inc. BiotechnologyHealth Technology MaveriX Oncology, Inc. operates as a a biotechnology company. It focuses on the discovery, development, and commercialization of targeted small molecule cancer chemo-immunotherapies. The company was founded by Steven A. Everett and Craig Alan Coburn in 2015 and is headquartered in Palo Alto, CA. | Directeur/Bestuurslid | 01-01-2014 | - |
| Algemeen Directeur | 01-01-2014 | - | |
| Oprichter | 01-01-2014 | - |
Loopbaan van Steven A. Everett
Eerdere bekende functies van Steven A. Everett
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University Of Dundee | Corporate Officer/Principal | 01-01-2005 | 01-01-2009 |
Spear Therapeutics Ltd.
 Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Oprichter | - | - |
| Corporate Officer/Principal | - | - | |
Cyterix Pharmaceuticals, Inc.
 Cyterix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyterix Pharmaceuticals, Inc. develops cancer therapeutics. It develops cancer therapeutics based on a proprietary OncoCY prodrug discovery approach. The company was founded by Paul R. Ortiz De Montellano, Luis Bayol and Steven A. Everett on April 10, 2010 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | 09-06-2011 | - |
| Algemeen Directeur | 08-06-2011 | - | |
| Hoofd Techniek/Wetenschap/O&O | 09-06-2011 | - | |
| Oprichter | 09-06-2011 | - | |
| President | 08-06-2011 | - |
Opleiding van Steven A. Everett
| University of Ulster | Undergraduate Degree |
| Brunel University | Masters Business Admin |
Statistieken
Internationaal
| Verenigd Koninkrijk | 5 |
| Verenigde Staten | 4 |
Operationeel
| Founder | 3 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Spear Therapeutics Ltd.
Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Health Technology |
Cyterix Pharmaceuticals, Inc.
Cyterix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyterix Pharmaceuticals, Inc. develops cancer therapeutics. It develops cancer therapeutics based on a proprietary OncoCY prodrug discovery approach. The company was founded by Paul R. Ortiz De Montellano, Luis Bayol and Steven A. Everett on April 10, 2010 and is headquartered in San Francisco, CA. | Health Technology |
MaveriX Oncology, Inc.
MaveriX Oncology, Inc. BiotechnologyHealth Technology MaveriX Oncology, Inc. operates as a a biotechnology company. It focuses on the discovery, development, and commercialization of targeted small molecule cancer chemo-immunotherapies. The company was founded by Steven A. Everett and Craig Alan Coburn in 2015 and is headquartered in Palo Alto, CA. | Health Technology |
- Beurs
- Insiders
- Steven A. Everett
- Ervaring
